您的位置：山东大学 -> 科技期刊社 -> 《山东大学学报（医学版）》

山东大学学报（医学版） ›› 2015, Vol. 53 ›› Issue (10): 73-81.doi: 10.6040/j.issn.1671-7554.0.2015.087

• 临床医学 • 上一篇    下一篇

肿瘤化疗患者应用植入式静脉输液港与PICC效果比较的系统评价

孙媛媛1,2, 高伟1, 崔英3, 张红1, 焦建芬1, 李衎2, 徐瑞彩2   

  1. 1. 山东大学齐鲁医院PICC门诊, 山东 济南 250012;
    2. 山东大学护理学院, 山东 济南 250012;
    3. 邹平县妇幼保健院门诊, 山东 邹平 256200
  • 收稿日期:2015-01-23 出版日期:2015-10-10 发布日期:2015-10-10
  • 通讯作者: 高伟。E-mail:gaoweisdu@163.com E-mail:gaoweisdu@163.com
  • 基金资助:
    山东省科技厅其他项目(26010104041413)

A systematic review on the effects of venous access port and PICC in cancer patients undergoing chemotherapy

SUN Yuanyuan1,2, GAO Wei1, CUI Ying3, ZHANG Hong1, JIAO Jianfen1, LI Kan2, XU Ruicai2   

  1. 1. PICC Clinic, Qilu Hospital of Shandong University, Jinan 250012, Shandong, China;
    2. School of Nursing, Shandong University, Jinan 250012, Shandong, China;
    3. Outpatient Clinic, Maternity and Child Health Care Hospital of Zouping County, Zouping 256200, Shandong, China
  • Received:2015-01-23 Online:2015-10-10 Published:2015-10-10

PDF (PC)

988

摘要： 目的 系统评价植入式静脉输液港(VAP)与经外周静脉穿刺中心静脉置管(PICC)在肿瘤化疗患者中的应用效果。方法 检索Co-chrane Library、Joanna Briggs Institute Library、MEDLINE、EMbase、Web of Knowledge、中国生物医学文献服务系统(CBM)、中国期刊全文数据库(CNKI)、万方数据资源系统及维普期刊资源整合服务平台(VIP)中关于肿瘤化疗患者应用VAP与PICC效果比较的随机对照试验、半随机对照试验、队列研究。由2位研究员按照纳入标准筛选文献、提取资料、评价质量,使用 RevMan 5.3软件对结局指标进行Meta分析与描述。结果 共纳入5项随机对照试验、1项半随机对照试验、16项队列研究,共3 278例患者。Meta 分析结果显示,VAP血栓发生率、导管相关性感染发生率均低于PICC[RR=0.31,95% CI(0.16,0.59);RR=0.39,95% CI(0.27,0.57)],但误入动脉发生率、气胸发生率均高于PICC[RR=8.70,95% CI(1.61,47.07);RR=6.12,95% CI(1.41,26.65)]。VAP患者生活质量B级以上的发生率较PICC高[RR=1.58,95% CI(1.38,1.82)]。描述性分析结果显示,VAP导管平均留置时间长于PICC。结论 VAP较PICC在延长导管留置时间、降低血栓及导管相关性感染发生率、改善肿瘤患者的生活质量方面具有优势,值得临床推广应用。但VAP置管过程中更应注意穿刺部位的解剖毗邻关系,以减少气胸及误入动脉的发生。

关键词: 系统评价, 经外周静脉穿刺中心静脉置管, Meta分析, 肿瘤, 植入式静脉输液港

Abstract: Objective To evaluate the effects of venous access port (VAP) and peripherally inserted central catheters (PICC) on cancer patients undergoing chemotherapy. Methods The relevant randomized controlled trials, quasi-randomized controlled trials and cohort studies on the comparison of PICC and VAP were searched in databases including Cochrane Library, Joanna Briggs Institute Library, MEDLINE, EMbase, Web of knowledge, CBM, CNKI, WanFang Data and VIP. Data obtained were extracted according to the inclusion and exclusion criteria by two reviewers independently. The quality of included studies was evaluated. A Meta-analysis was conducted using RevMan 5.3 software. Results Altogether 5 randomized controlled trials, 1 quasi-randomized controlled trial, and 16 cohort studies involving 3,278 patients were included. The results of Meta-analysis showed that VAP was associated with a significantly lower incidence of thrombosis and catheter-associated infection than PICC[RR=0.31, 95% CI(0.16, 0.59); RR=0.39, 95% CI (0.27, 0.57)]. However, the incidence of the stray into the artery and pneumothorax was higher than PICC[RR=8.70, 95% CI (1.61, 47.07); RR=6.12, 95% CI (1.41, 26.65)]. Patients' quality of life was higher afterVAP than PICC [RR=1.58, 95% CI (1.38, 1.82)]. The descriptive analysis showed that VAP had longer catheter indwelling time than PICC. Conclusion VAP has advantages in prolonging catheter indwelling time, decreasing the incidence of thrombosis and catheter-associated infection, and improving patients' quality of life. Therefore, it is worth to be promoted in clinical practice. However, to perform VAP, special attention should be paid to the adjacent anatomical relations of the puncture site during catheterization process, in order to reduce the incidence of pneumothorax and stray into the artery.

Key words: Venous access port, Neoplasms, Peripherally inserted central catheters, Systematic review, Meta-analysis

中图分类号: 

  • R472.9
[1] 唐鹏琳, 陈利芬, 成守珍, 等. 化疗患者应用PICC与植入式静脉输液港的比较[J]. 中国护理管理, 2014, 14(4):420-422. TANG Penglin, CHEN Lifen, CHENG Shouzhen, et al. The maintenance comparison of applying PICC and VPA among cancer patients undergoing chemotherapy[J]. Chinese Nursing Management, 2014, 14(4):420-422.
[2] Beckers MM, Ruven HJ, Seldenrijk CA, et al. Risk of thrombosis and infections of central venous catheters and totally implanted access ports in patients treated for cancer[J]. Thromb Res, 2010, 125(4):318-321.
[3] Higgins JP, Green S. Cochrane Handbook for Systematic Reviews of Interventions (Version 5.1.0)[EB/OL]. [2012-01-05]. http://www.cochrane-handbook.org.
[4] Wells G, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses[EB/OL]. [2012-06-15]. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
[5] 胡雁, 李晓玲. 循证护理的理论与实践[M]. 上海:复旦大学出版社, 2007:30-40, 49, 74-78.
[6] 李红艳. 乳腺癌患者对 PICC 和静脉输液港满意度的比较与研究[J]. 世界最新医学信息文摘, 2014, 14(21):224.
[7] 王邓超, 林瑞娇, 张再重, 等. 植入式静脉输液港与外周静脉穿刺中心静脉置管在乳腺癌辅助化疗中的应用比较[J]. 中华内分泌外科杂志, 2014, 8(2):120-122. WANG Dengchao, LIN Ruijiao, ZHANG Zaizhong, et al. Comparison of venous port access and peripherally inserted central catheters in adjuvant chemotherapy for patients with breast cancer[J]. Chin J Endocr Surg, 2014, 8(2):120-122.
[8] 曾云菲, 罗丹丹. 比较PICC与植入式静脉输液港在白血病患者长期化疗中的应用评价[J]. 吉林医学, 2014, 35(23):5277.
[9] 郅丽, 高铭云, 黄小珍, 等. 超声实时引导 PICC 与植入式静脉输液港在肿瘤患者应用的比较[J].广西医学, 2014, 36(5):694-695.
[10] 郑明康, 陈辉. 外周静脉置入中心静脉导管与植入式静脉输液港在乳腺癌化疗中的应用[J]. 中国医药导报, 2014, 11(29):47-50. ZHENG Mingkang, CHEN Hui. Comparison of peripherally inserted central catheter and totally implantable venous access port in chemotherapy of breast cancer[J]. China Medical Herald, 2014, 11(29):47-50.
[11] 于瑞, 陈利芬, 唐鹏琳, 等. 不同中心静脉输液途径对乳腺癌患者置管并发症发生的影响[J]. 现代临床护理, 2014, 13(8):40-43. YU Rui, CHEN Lifen, TANG Penglin, et al. Effects of different approaches to central venous catheterization on complication incidence of breast tumor[J]. Modern Clinical Nursing, 2014, 13(8):40-43.
[12] 尹悦. PICC与VPA在肺癌患者化疗中的应用比较[J]. 江苏医药, 2014, 40(3):369-371.
[13] 张丽娟, 辛明珠, 张慧珍, 等. 乳腺癌病人留置PICC与VPA化疗的临床效果比较[J]. 护理研究, 2013, 27(18):1845-1846. ZHANG Lijuan, XIN Mingzhu, ZHANG Huizhen, et al. Comparison of clinical effects of indwelling PICC and VPA chemotherapy for patients with breast cancer[J]. Chinese Nursing Research, 2013, 27(18):1845-1846.
[14] 莫美珍, 林称喜, 钟华英, 等. 乳腺癌患者应用植入式静脉输液港与PICC的效果比较[J]. 中国实用护理杂志, 2013, 29(24):19-20.
[15] 潘小为, 侯秋秀, 罗金玲. 植入式静脉输液港与中心静脉导管降低感染的效果比较[J]. 中华医院感染学杂志, 2013, 23(14):3364-3365. PAN Xiaowei, HOU Qiuxiu, LUO Jinling. Comparison of effect between implanted venous port and PICC on decreasing infections[J]. Chin J Nosocomiol, 2013, 23(14):3364-3365.
[16] 何越, 孙艳萍, 李宁, 等. 血液恶性肿瘤患者应用PICC与植入式静脉输液港的效果比较[J]. 中华护理杂志, 2012, 47(11):1001-1003. HE Yue, SUN Yanping, LI Ning, et al. Comparison of the effects of PICC and venous access port in patients with hematological malignancies[J]. Chin J Nurs, 2012, 47(11):1001-1003.
[17] 倪霞, 张天华. PICC与VPA两种深静脉置管术在肺癌患者中的应用比较[J]. 浙江实用医学, 2011, 16(3):232-233.
[18] 郑雪贞. 植入式静脉输液港与PICC导管在白血病化疗中的应用比较[J]. 福建医药杂志, 2011, 33(4):175-176.
[19] 张学强. 植入式中心静脉输液港与经外周静脉中心静脉置管在恶性肿瘤患者中应用的对比研究[J]. 疑难病杂志, 2009, 8(9):553-554.
[20] 葛峰, 仓静, 薛张纲. 皮下埋藏式中心静脉导管应用于肿瘤化疗患者的临床效果[J]. 中华医学杂志, 2008, 88(33):2331-2334. GE Feng, CANG Jing, XUE Zhanggang. Safety and effectiveness of central vein catheters indwelling with subcutaneous port in patients undergoing chemotherapy[J]. Natl Med J China, 2008, 88(33):2331-2334.
[21] 马新娟, 张艳华, 郑卫红. PICC与VPA在白血病患者中的应用比较[J]. 护士进修杂志, 2008, 23(19):1807-1808.
[22] Patel GS, Jain K, Kumar R, et al. Comparison of peripherally inserted central venous catheters (PICC) versus subcutaneously implanted port-chamber catheters by complication and cost for patients receiving chemotherapy for non-haematological malignancies[J]. Support Care Cancer, 2014, 22(1):121-128.
[23] Cotogni P, Pittiruti M, Barbero C, et al. Catheter-related complications in cancer patients on home parenteral nutrition:a prospective study of over 51,000 catheter days[J]. JPEN J Parenter Enteral Nutr, 2013, 37(3):375-383.
[24] Bratton J, Johnstone PA, McMullen KP. Outpatient management of vascular access devices in children receiving radiotherapy:complications and morbidity[J]. Pediatr Blood Cancer, 2014, 61(3):499-501.
[25] Jain SA, Shukla SN, Talati SS, et al. A retrospective study of central venous catheters GCRI experience[J]. Indian J Med Paediatr Oncol, 2013, 34(4):238-241.
[26] Revel-Vilk S, Yacobovich J, Tamary H, et al. Risk factors for central venous catheter thrombotic complications in children and adolescents with cancer[J]. Cancer, 2010, 116(17):4197-4205.
[27] Kim HJ, Yun J, Kim HJ, et al. Safety and effectiveness of central venous catheterization in patients with cancer:prospective observational study[J]. J Korean Med Sci, 2010, 25(12):1748-1753.
[28] 江海云, 唐瑶. 失效模式效应分析在减少PICC非计划拔管中的应用[J]. 中国实用护理杂志, 2013, 29(18):63-65. JANG Haiyun, TANG Yao. Application of FMEA in reducing unplanned extubation of PICC[J]. Chin J Prac Nurs, 2013, 29(18):63-65.
[29] 赵洁. 40例白血病患者PICC非计划拔管原因分析与对策[J]. 中华护理杂志, 2007, 42(2):174-175.
[30] 国家卫生和计划生育委员会. 静脉治疗护理技术操作规范[J]. 中国护理管理, 2014, 14(1):1-3.
[31] 李海洋,黄金, 高竹林. 完全植入式静脉输液港应用及护理进展[J].中华护理杂志, 2012, 47(10):953-955.
[32] Saber W, Moua T, Williams EC, et al. Risk factors for catheter-related thrombosis (CRT) in cancer patients:a patient-level data (IPD) meta-analysis of clinical trials and prospective studies[J]. J Thromb Haemost, 2011, 9(2):312-319.
[33] Evans RS, Sharp JH, Linford LH, et al. Risk of symptomatic DVT associated with peripherally inserted central catheters[J]. Chest, 2010, 138(4):803-810.
[34] Bouza E, Burillo A, Muoz P. Catheter-related infections:diagnosis and intravascular treatment[J]. Clin Microbiol Infect, 2002, 8(5):265-274.
[1] 王伟 王沂峰 张岭梅 林琼燕 黄菊. 人卵巢癌OVCAR3细胞系中侧群细胞的分离及其成瘤性、侵袭性的实验研究[J]. 山东大学学报(医学版), 2209, 47(6): 8-11.
[2] 张士宝 刘庆勇 阮喜云 陈杰 张建军 李宗武 杨广笑 王全颖. NT4-SAC-HA2-TAT融合基因表达载体的构建及鉴定[J]. 山东大学学报(医学版), 2209, 47(6): 15-19.
[3] 李波波 李道堂 刘曙光 王兴武. 食管癌患者血清中DKK-1的表达[J]. 山东大学学报(医学版), 2209, 47(6): 58-61.
[4] 鹿向东 杨伟 徐广明 曲元明. 脑膜瘤中PPAR-γ的表达及曲格列酮对脑膜瘤培养细胞生长的影响[J]. 山东大学学报(医学版), 2209, 47(6): 65-.
[5] 黄方 康瑞 吴春林. VEGFC、NF-κBp65及Survivin在鼻咽癌中的表达及临床意义[J]. 山东大学学报(医学版), 2209, 47(6): 83-.
[6] 林明霞,刘桂斌,马燕花,连曌昱,任洋洋. ATP酶铜转运蛋白α介导的铜死亡途径及在肿瘤治疗中的价值[J]. 山东大学学报 (医学版), 2026, 64(4): 117-124.
[7] 邹宇锦,万熠,纪振冰,梁西昌. 促骨再生-抗肿瘤双功能钛合金植入体的生物实验研究[J]. 山东大学学报 (医学版), 2026, 64(2): 50-65.
[8] 李雪凯,孙淋涵,刘端瑞,倪阳. 乳酸化修饰在肿瘤炎癌进程中的功能与机制研究进展[J]. 山东大学学报 (医学版), 2025, 63(9): 65-76.
[9] 王雪梅,杨豪,宋洋,程世超,张婷婷,王艳春. 抗糖尿病药物与女性恶性肿瘤的因果关联:一项两样本孟德尔随机化分析[J]. 山东大学学报 (医学版), 2025, 63(6): 67-77.
[10] 温学龙,刘安慧,陈经纬,吴梦婷,杨岷. 急性非ST抬高型心肌梗死行冠状动脉旁路移植手术时机Meta分析[J]. 山东大学学报 (医学版), 2025, 63(5): 60-70.
[11] 赵汉卿,周新睿,李子建,唐兴. 循环肿瘤细胞联合血清学检测在非小细胞肺癌中的应用[J]. 山东大学学报 (医学版), 2025, 63(5): 79-85.
[12] 黄馨,王梦雪,付书璠,张琦悦,徐力. 代谢综合征及其组分与消化系统恶性肿瘤的因果关联:两样本孟德尔随机化研究[J]. 山东大学学报 (医学版), 2025, 63(5): 86-94.
[13] 杜雪,李春霞,刘云霞,张涛. 基于MFPC-Cox的结直肠癌患者预后动态预测模型[J]. 山东大学学报 (医学版), 2025, 63(5): 101-110.
[14] 王宝炫,焦杰,张厚君,刘奇,于冠英. 衰弱与肌少症评估在胃肠道肿瘤术后结局预测中的应用与展望[J]. 山东大学学报 (医学版), 2025, 63(4): 51-58.
[15] 宋雅雯,郭联涛,孔德光,孙圣荣. VTCN1导致HR+乳腺癌预后不良及内分泌治疗耐药[J]. 山东大学学报 (医学版), 2025, 63(1): 43-59.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
版权所有 © 2018 《山东大学学报(医学版)》编辑部　
地址:山东大学科技期刊社（济南市历城区山大南路27号山东大学中心校区明德楼B座721室） 电话: 0531-88366918 E-mail: xbyxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发